EMTAK 21201

Ravimite jm farmaatsiatoodete tootmine

EMTAK 21201 · 21 companies operate in this sector. 14 of them have revenue. Median revenue is 187,081 € and median revenue per employee 90,313 €. 2 companies have tax debt.

Companies
21
With revenue
14
Median revenue
187,081 €
Median revenue per employee
90,313 €
Monthly labour cost per employee (median)
2,842 €
With tax debt
2
Monthly labour cost per employee includes employer taxes. It is not take-home pay.

Companies in this sector

Registered
Advagen Pharma Europe OÜ15.05.2023
Bravo Diagnostics OÜ16.02.2017
Cetreva OÜ27.12.2019
HoneyMedical OÜ28.06.2018
Hydrogen Energy OÜ23.07.2020
Interchemie Werken De Adelaar Eesti aktsiaselts31.01.1996
LOODUSMARK OÜ03.06.2005
Marlamed OÜ11.07.2025
NanoElectronics OÜ29.04.2013
Naqua EU OÜ03.09.2025
Osaühing EbeKar09.09.1996
OÜ Milvesta05.04.2001
OÜ Raba Vägi24.01.2013
PharmaEstica Manufacturing OÜ19.09.1997
PharmaPark Production OÜ02.05.2023
Ravim OÜ19.02.2018
Richter Gedeon Vegyeszeti Gyar Reszvenytarsasag Eesti Filiaal20.06.1996
TALLINNA FARMAATSIATEHASE AKTSIASELTS16.09.1996
UAB Teva Baltics Eesti filiaal21.12.2006
Ülejõe neumad OÜ07.08.2014
Vipis Pharmaceutics OÜ02.01.2012

Highest-revenue companies

92% of 2025 annual reports have been filed. Larger companies file later: 178 companies whose revenue exceeded €10M the previous year have not yet filed for 2025.

Related sectors

Data as of 13.10.2026 Source: Estonian Business Register open data (RIK) and Estonian Tax and Customs Board open data. Each row shows the financial year the figure comes from.